Welcome to LookChem.com Sign In|Join Free
  • or
(R)-1-BOC-3-ISOBUTYLPIPERAZINE, also known as N-tert-Butoxycarbonyl-3-isobutylpiperazine, is a chemical compound that belongs to the class of piperazine derivatives. It is characterized by a piperazine ring with an isobutyl group and a t-Boc protecting group attached to it. (R)-1-BOC-3-ISOBUTYLPIPERAZINE has a molecular formula of C13H25N3O2 and a molecular weight of 251.35 g/mol. It is used in organic synthesis and pharmaceutical research, particularly in the development of potential therapeutic agents, and has been studied for its potential pharmacological properties, including its anticonvulsant and psychotropic effects.

928025-61-0

Post Buying Request

928025-61-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

928025-61-0 Usage

Uses

Used in Pharmaceutical Research:
(R)-1-BOC-3-ISOBUTYLPIPERAZINE is used as a key intermediate in the synthesis of various pharmaceutical compounds for the development of potential therapeutic agents. Its unique chemical structure and properties make it a valuable building block in the creation of new drugs with improved efficacy and safety profiles.
Used in Organic Synthesis:
(R)-1-BOC-3-ISOBUTYLPIPERAZINE serves as a versatile starting material in organic synthesis, allowing for the preparation of a wide range of chemical compounds. Its t-Boc protecting group can be selectively removed under mild conditions, enabling the synthesis of various piperazine-based derivatives with diverse functional groups and applications.
Used in Medicinal Chemistry:
(R)-1-BOC-3-ISOBUTYLPIPERAZINE is employed as a scaffold in medicinal chemistry for the design and optimization of novel drug candidates. Its pharmacological properties, such as anticonvulsant and psychotropic effects, make it a promising candidate for the treatment of various neurological and psychiatric disorders.
Used in Drug Development:
(R)-1-BOC-3-ISOBUTYLPIPERAZINE is utilized in drug development to explore its potential as a therapeutic agent for various diseases and conditions. Its unique chemical structure and pharmacological properties provide a foundation for the discovery of new drugs with improved therapeutic benefits and reduced side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 928025-61-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,8,0,2 and 5 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 928025-61:
(8*9)+(7*2)+(6*8)+(5*0)+(4*2)+(3*5)+(2*6)+(1*1)=170
170 % 10 = 0
So 928025-61-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H26N2O2/c1-10(2)8-11-9-15(7-6-14-11)12(16)17-13(3,4)5/h10-11,14H,6-9H2,1-5H3/t11-/m1/s1

928025-61-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl (3R)-3-(2-methylpropyl)piperazine-1-carboxylate

1.2 Other means of identification

Product number -
Other names (3R)-3-(2-Methylpropyl)-1-piperazinecarboxylic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:928025-61-0 SDS

928025-61-0Upstream product

928025-61-0Downstream Products

928025-61-0Relevant academic research and scientific papers

Expedite protocol for construction of chiral regioselectively N-protected monosubstituted piperazine, 1,4-diazepane, and 1,4-diazocane building blocks

Crestey, Francois,Witt, Matthias,Jaroszewski, Jerzy W.,Franzyk, Henrik

supporting information; experimental part, p. 5652 - 5655 (2009/12/08)

(Chemical Equation Presented) This paper describes the first study of solution-phase synthesis of chiral monosubstituted piperazine building blocks from nosylamide-activated aziridines. The protocol, involving aminolysis of the starting aziridines with ω-amino alcohols and subsequent Fukuyama-Mitsunobu cyclization, offers the advantage of mild conditions as well as short reaction times, and it leads to optically pure N-Boc- or N-Ns-protected piperazines. This four-step sequence, requiring only a single final chromatographic purification, was extended to include novel diazepane and diazocane derivatives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 928025-61-0